- Agency Report
At least eight persons have been killed by suspected Buruli ulcer outbreak in Malabu community, Fufore Local Government Area of Adamawa state.
The state Commissioner for Health, Dr Felix Tangwami, disclosed this to journalists on Tuesday in Yola.
He said the government is deeply concerned, noting that some victims are currently receiving treatment at the Modibbo Adama University Teaching Hospital, Yola.
According to the World Health Organisation (WHO), Buruli ulcer is a chronic debilitating disease caused by an environmental Mycobacterium ulcerans.
The bacterium produces a toxin that causes the skin damage and can lead to long-term disability if not treated early enough.
The germ that causes Buruli ulcer belongs to the same family of those that cause tuberculosis and leprosy.
Meanwhile, Tangwami revealed that samples have already been collected and dispatched to the National Reference Laboratory for further testing.
According to him, health officials have placed the community under close monitoring to prevent further spread of the suspected disease.
The Commissioner assured that the state, in collaboration with the Federal Ministry of Health, WHO, and partners, is taking proactive steps to contain the situation.
“Our medical team is working round the clock to stabilise the victims’ condition,” he said.
Tangwami added that measures include deployment of emergency response teams, awareness campaigns, and provision of medical supplies to the affected community.
He urged the residents to remain calm, avoid panic, and maintain good hygiene practices.
The Commissioner also advised them to report suspicious cases to health facilities and avoid patronising traditional remedies to prevent worsening infections.
At least 33 countries with tropical, subtropical and temperate climates have reported Buruli ulcer in Africa, South America and Western Pacific regions.
Buruli ulcer, according to WHO, often starts as a painless swelling (nodule), a large painless area of induration (plaque) or a diffuse painless swelling of the legs, arms or face (oedema).
The disease may progress with no pain and fever.